ON LYMPHOCYTE ENGINEERING 2022
Featured Speakers
Adi Barzel
President of the Israeli Society for Gene and Cell Therapy (ISGCT), ICLE Conference Chair, Senior lecturer at Tel-Aviv University, IsraelAdi Barzel
President of the Israeli Society for Gene and Cell Therapy (ISGCT), ICLE Conference Chair, Senior lecturer at Tel-Aviv University, Israel
Dirk Busch
MD, Director, Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, GermanyDirk Busch
MD, Director, Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Germany
Chiara Bonini
MD, Deputy Director, Division of Immunology, Transplantation and Infectious Diseases; Head, Experimental Haematology Unit; Full professor, Vita-Salute San Raffaele University, ItalyChiara Bonini
MD, Deputy Director, Division of Immunology, Transplantation and Infectious Diseases; Head, Experimental Haematology Unit; Full professor, Vita-Salute San Raffaele University, Italy
Malcolm Brenner
MD, PhD, Founding Director, Center for Cell and Gene Therapy, Baylor College of Medicine, USAMalcolm Brenner
MD, PhD, Founding Director, Center for Cell and Gene Therapy, Baylor College of Medicine, USA
Michel Sadelain
MD, PhD, Director, Center for Cell Engineering; Stephen and Barbara Friedman Chair, Memorial Sloan Kettering Cancer Center, USAMichel Sadelain
MD, PhD, Director, Center for Cell Engineering; Stephen and Barbara Friedman Chair, Memorial Sloan Kettering Cancer Center, USA
Hans Stauss
MD, PhD, Director Institute of Immunity and Transplantation; Co-Director Division of Infection and Immunity University College London; Head Clinical Immunology Royal Free London, NHS Foundation Trust, UKHans Stauss
MD, PhD, Director Institute of Immunity and Transplantation; Co-Director Division of Infection and Immunity University College London; Head Clinical Immunology Royal Free London, NHS Foundation Trust, UK
Stan Riddell
MD, Director, Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center; Professor, Department of Medicine at the University of Washington, USAStan Riddell
MD, Director, Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center; Professor, Department of Medicine at the University of Washington, USAExhibitors & Sponsors
Expanding the Paradigm of Immuno-Gene Therapy
With ground-breaking clinical success and exponentially growing research leading to FDA approved products, lymphocyte engineering is the way of the future. Be part of it! Join us for the 3rd International Conference on Lymphocyte Engineering - where the world`s health innovators in immuno-gene therapy come together.
The ICLE Advantage
ICLE is one of the cornerstone conferences on lymphocyte engineering. Top quality of the scientific program, perfect networking opportunities and the leading scientists and experts in the field are the main benefits of attending shared by our community members. Join us as we lead the future in lymphocyte engineering.
